FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of pharmaceuticals, namely the use of 3-O-sulfamate 16,16-dimethyl-D-homoequilenin of formula (1) for treatment of endometriosis.
EFFECT: provided is use of 3-O-sulfamate 16,16-dimethyl-D-homoequilenin, which is highly effective in reducing endometrioid foci, as a monotherapy agent for treatment of endometriosis through the aromatase inhibition mechanism.
(1)
1 cl, 1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ENDOMETRIOSIS IN EXPERIMENT IN RATS | 2023 |
|
RU2816983C1 |
| METHOD OF ENDOMETRIOSIS TREATMENT BASED ON AN EXPERIMENTAL MODEL IN RATS | 2019 |
|
RU2711615C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2732251C1 |
| METHOD FOR INTEGRATED TREATMENT OF EXTERNAL GENITAL ENDOMETRIOSIS | 2013 |
|
RU2541089C1 |
| METHOD FOR FORMING AN EXPERIMENTAL MODEL OF A COMBINATION OF TYPE 1 DIABETES MELLITUS AND ENDOMETRIOSIS | 2021 |
|
RU2776727C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2711658C1 |
| METHOD FOR MODELING JUVENILE ENDOMETRIOSIS USING A XENOGRAFT MODEL | 2022 |
|
RU2789591C1 |
| METHOD OF EARLY DIAGNOSTICS OF REASONABILITY OF CONSERVATIVE TREATMENT OF INTERNAL ENDOMETRIOSIS OF CORPUS UTERI | 2011 |
|
RU2459582C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2018 |
|
RU2693050C1 |
| DIAGNOSTIC TECHNIQUE IN ENDOMETRIOID OVARIAN CYSTS | 2012 |
|
RU2480761C1 |
